已发表论文

阿托品治疗右美托咪定相关心动过缓的严重高血压反应:病例报告和文献综述

 

Authors Li Y, Gao J, Jiang L, Sun C, Hong H, Yu D

Received 26 September 2023

Accepted for publication 23 December 2023

Published 11 January 2024 Volume 2024:16 Pages 27—31

DOI https://doi.org/10.2147/CPAA.S436188

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Professor Arthur E. Frankel

Abstract: Dexmedetomidine is a selective and potent α2-adrenoceptor agonist used for sedation, analgesia, and anxiolysis, with minimal respiratory depression; therefore, it is widely used in clinical practice. Transient hypertension has been reported to be an indication for the use of dexmedetomidine. The authors report three female patients who experienced hypertensive crisis when used atropine to treat bradycardia caused by dexmedetomidine. The transient hypertension is a relatively common side effect of dexmedetomidine, hypertensive crisis seen with coadministration of atropine is much less frequently reported. This is the first report to describe the use of atropine to treat bradycardia induced by dexmedetomidine, which may cause severe hypertension in female patients. They discuss the reason for and treatment of hypertension caused by administration of atropine and dexmedetomidine together and review the relevant literature.

Keywords: dexmedetomidine, atropine, bradycardia, hypertension